{{ subpage.title }}

What We're Watching: Israel's fourth shot, Nordic NATO jitters, EU nuclear debate heats up

Fourth time’s the charm in Israel. As the COVID omicron variant sweeps the globe, Israel has become the first country to roll out a fourth vaccine shot for health care workers, immunocompromised residents, and people over the age of 60. (The eligibility criteria will likely be broadened in the weeks ahead.) Pushing back against those who say that more research is required to gauge the effectiveness of a fourth shot, Prime Minister Naftali Bennett said that omicron is “a new ballgame altogether.” This comes as Israel's health ministry said recently that the country could soon reach herd immunity due to a combination of vaccination rates (64 percent of the population is fully vaccinated) and mounting infections (Bennett warned Sunday that daily infections could soon reach 50,000, up from the current daily caseload of 6,500). Israeli health officials say that although omicron’s spread is inevitable, the aim is to keep deaths and hospitalizations as low as possible by keeping inoculation rates sky-high. Will other countries follow suit?

Read Now Show less
The Race to Vaccinate | Biden COVID-19 Adviser, Dr. Atul Gawande | GZERO World

The race to vaccinate: Dr. Atul Gawande provides perspective

Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Subscribe to GZERO Media's newsletter, Signal

Latest